Osama F Elabi, Shubhangini Tiwari, Alba M Garcia-Serrano, Robert Carlsson, Carlos Noriega Polo, Luis A Fonseca-Fonseca, João M N Duarte, Gesine Paul
Diet-induced metabolic dysregulation is associated with cerebral microvascular pathology contributing to cognitive decline and vascular dementia. These alterations include blood-brain barrier (BBB) leakage, pericyte dysfunction, aberrant angiogenesis, and perivascular neuroinflammation. Restoration of BBB integrity has been achieved in other conditions by targeting pericytes, for example through knockout of Regulator of G-protein Signaling 5 (RGS5), a sensor protein for hypoxia and oxidative stress highly enriched in these cells. It remains unclear whether deletion of RGS5 can provide vascular protection in conditions of chronic metabolic stress and prevent cognitive impairment despite ongoing metabolic dysfunction. We used constitutional RGS5 knockout (KO) mice and wildtype (WT) controls fed a standard or high-fat diet (HFD) for 23 weeks to induce metabolic dysfunction, confirmed by weight gain, insulinemia, and impaired glucose tolerance. BBB leakage, vascular pathology (vessel density, branching, pericyte density and coverage), microglial activation and microglia-capillary interactions were analyzed using immunohistochemistry. Spatial memory was evaluated using the novel object location test. HFD induced obesity, glucose intolerance and insulin resistance in all mice. In WT but not RGS5-KO mice, HFD caused BBB leakage, immature angiogenesis, and pericyte activation. RGS5 deletion also prevented microglial activation and enhanced interactions between resting microglia and striatal vessels. Importantly, HFD-induced impairment of spatial memory was prevented in KO mice. These data suggest that deletion of RGS5 preserves BBB integrity, maintains microvascular homeostasis, reduces neuroinflammation, and ameliorates memory decline in diet-induced metabolic dysfunction. These findings highlight RGS5 as potential therapeutic target and emphasize microvascular dysfunction as contributor to HFD-induced cognitive decline.